Article info
PDFNovel treatment (new drug/intervention; established drug/procedure in new situation)
Case report
Low-dose naltrexone as a treatment for chronic fatigue syndrome
- Correspondence to Professor Harm Van Marwijk; H.vanMarwijk{at}bsms.ac.uk
Citation
Low-dose naltrexone as a treatment for chronic fatigue syndrome
Publication history
- Accepted October 13, 2019
- First published January 6, 2020.
Online issue publication
January 06, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.